137
83. Circulating cytokines as markers of systemic inflammatory response in severe
community-acquired pneumonia / A.A.
et al.] //
– 2004. –
Vol. 37, № 3. – P. 204-209.
84. Community-acquired pneumonia among the elderly: differences between
patients living at home and in nursing homes / E.
/
– 2004. – Vol. 40, № 12. – P. 547-552.
85. Community-acquired pneumonia in a central hospital - comparison between a
group of elderly and a non-elderly patients / S.
et al.] //
– 2003. – Vol. 9, № 5. – P. 7-8.
86.
Community-acquired pneumonia in the elderly: Spanish multicentre study / R.
Zalacain, A. Torres [et al.] // Eur. Respir. J. – 2003. - Vol. 21. – P. 294-302.
87. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy
and safety of moxifloxacin therapy versus that of levofloxacin therapy / A.
[et al.]
– 2006. – Vol. 42, № 1. – P. 73-81.
88. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study / C.
et al.] //
– 1999. – Vol. 27, № 9. – P. 1745-1753.
89. Cytokine profiles in alveolar macrophages of patients with ILD, COPD and
acute pneumonia / T.Welte [et al.] // Eur. Respir. J. – 1998. – Vol. 12, № 28. – P.
2088.
90. Determinants of short and long term functional recovery after hospitalization
for community-acquired pneumonia in the elderly: role of inflammatory markers / A.
et al.] //
– 2006. – Vol. 6. – P. 12.
91. Epidemiology of community- acquired pneumonia in adult patients at the dawn
of the 21
st
century: a prospective study on the Mediterranean coast of Spain / F.
Gutierrez, M. Masia, J.C. Rodriguez [et al.] // Clin. Microbiol. And Infect. – 2005. -
№ 11(10). – P. 788-800.
92.
Epidemiology of community- acquired pneumonia in older adults: a
population - based study / A. Vila-Corcoles [et al.] // Respir. Medicine. – 2009. - Vol.
103. – P. 309-316.